EUROMEDICA  Hanover 6-7  Juni 2008	Advanced methods of diagnosis, treatment and prophylactics
	European Academy of Natural Sciences, Hanover European Scientific Society, Hanover Russian Academy of Natural Sciences, Moscow

Home

Abstracts

Contact

Disclaimer

Background. Encephalopathy due to brain dyscirculation is a widespread pathology, which may impair a quality of life and even lead to inability of patients. The original device complex «Bioregulator-004 M» allows to apply a new modification of volumetric pneumopressing as a pathogenetic treatment of encephalopathy. Artificial acceleration of local blood flow provides certain shear stress on vascular endothelium and causes enhanced secretion of endothelial cells with following vasodilatation, antithrombotic effects and improvement of blood rheology. These processes are explained by NO accumulation, releasing of prostacyclin and plasminogen activators resulted in activation of microcirculation, local and general blood- and lymph flow, venous outflow, tissue trophic and reparation, restoration of organ function. Clinical effects of proposed technique also include antiedematic, detoxication, analgetic and sedation influences.

Methods. We observed 65 patients (35 male) aged from 55 to 65 years with confirmed dyscirculatory encephalopathy II-III degree (both atherosclerotic and hypertonic genesis). Vestibulopathy was diagnosed in 9 cases and extrapyramidal disorders in 7 patients. 3 male and 2 female suffered from ischemic stroke 1-3 years ago with residual mild unilateral hemiparesis. Complains of each patient reflected the level of his/her functional and organic damages. All patients were treated by original device complex «Bioregulator-004 M», which operates with programmed interval regimens of dosing air pressure in multiple hermetically connected with each-other compartments formed universal pneumocuff. This pneumocuff-transformer can modulates for press out of different body parts including head (pneumocuff “cap”). Complex was designed and developed by doctor of technical science, academician I.Tarshinov and approved by Health Ministry of Ukraine for medical usage (State Register of medical products No. 237, 1995.12.22).

The treatment course consisted of pneumopressing programmes which were adjusted individually for each patient according to impact direction, time and intensity.

Results. After 10-12 sessions of apparatus treatment we registered significant improvement in patients’ psycho-emotional status and sleep, decreasing of blood pressure, reduction or disappearance of headache, vertigo and walking instability, particular restoration of memory, enhancing of capability. Ophthalmologist noted vision improvement with glasses correction by 1-2 dioptries in 4 patients.

Conclusions. Considering the above presented results and an available practical experience of our organization, it is possible to recommend application of the method of volumetric pneumopressure by original equipment complex «Bioregulator-004 M» in pathogenetic and rehabilitation treatment of chronic cerebrovascular disorders.